2 months ago
MRK
AnalystsEvan David SeigermanEvan David Seigerman's Stock Forecasts
AnalystsEvan David Seigerman
Sectors:
Industries:
Analyst Ranking
Top 19%
#1017 out of 5550 analysts
Average Return
+9.83%
Win Rate
57%34 out of 60
Risk vs Reward
Poor
Good
Evan David Seigerman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Candel Therapeutics IncCADL | +568.75% | $1.60 | $10.70 | 2023-05-15 - 2024-05-14 | Buy |
Morphic Holding IncMORF | +147.53% | $22.49 | $55.67 | 2023-09-28 - 2024-07-09 | Buy |
Eli Lilly & CoLLY | +81.93% | $306.82 | $558.19 | 2022-09-06 - 2023-09-05 | Buy |
Merus NvMRUS | +63.22% | $55.14 | $90.00 | 2025-05-23 - 2025-12-29 | Buy |
Merck & Co IncMRK | +48.50% | $100.69 | $149.52 | 2025-12-18 - 2026-10-30 | Buy |
Evan David Seigerman Analyst Color
Get additional color on Evan David Seigerman's coverage of popular stocks
10 months ago
MRK
a year ago
NVO
a year ago
NVO
2 years ago
NVO
2 years ago
MRK
2 years ago
NVO
3 years ago
PFE
Evan David Seigerman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Disc Medicine IncIRON | 3 | Buy | $120.00 | +48.44% | Maintains | 13 days ago |
Novo Nordisk A SNVO | 9 | Hold | $40.00 | 0.00% | Maintains | 20 days ago |
Amgen IncAMGN | 8 | Hold | $415.00 | -10.95% | Maintains | 20 days ago |
Acadia Pharmaceuticals IncACAD | 4 | Buy | $34.00 | +65.13% | Maintains | a month ago |
Merck & Co IncMRK | 7 | Buy | $170.00 | +13.70% | Maintains | 2 months ago |
Pfizer IncPFE | 5 | Buy | $30.00 | -1.70% | Maintains | 4 months ago |
Abbvie IncABBV | 9 | Buy | $300.00 | +1.73% | Maintains | 4 months ago |
Regeneron Pharmaceuticals IncREGN | 10 | Buy | $730.00 | -21.33% | Maintains | 5 months ago |
Replimune Group IncREPL | 5 | Hold | $11.00 | -37.54% | Upgrades | a year ago |
Neurogene IncNGNE | 2 | Buy | $26.00 | N/A | Maintains | a year ago |
Merus NvMRUS | 1 | Buy | $110.00 | N/A | Maintains | a year ago |
Arvinas IncARVN | 1 | Buy | $10.00 | N/A | Maintains | a year ago |
Morphic Holding IncMORF | 3 | Hold | $57.00 | N/A | Downgrades | 2 years ago |
Structure Therapeutics IncGPCR | 2 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 4 | Hold | $72.00 | N/A | Maintains | 3 years ago |
Candel Therapeutics IncCADL | 1 | Buy | $3.00 | N/A | Maintains | 3 years ago |
Eli Lilly & CoLLY | 1 | Buy | $396.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.